Oral Therapy using Anti-Oxidants for Alzheimer's Disease

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AG023456-01A1
Agency Tracking Number: AG023456
Amount: $100,816.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
NANOTHERAPEUTICS, INC.
NANOTHERAPEUTICS, INC., 12085 RESEARCH DR, STE N, ALACHUA, FL, 32615
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 BARBEL Eppler
 (386) 462-9663
 JTALTON@NANOTHERAPEUTICS.COM
Business Contact
 JAMES TALTON
Phone: (386) 462-9663
Email: JTALTON@NANOTHERAPEUTICS.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Nanotherapeutics proposes to evaluate oral taurine therapy for Alzheimer's disease (AD). AD, the most common form of dementia among older people, affects over 4 million Americans. It requires full-time care in the

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government